stage II cutaneous T-cell non-Hodgkin lymphoma
Showing 9976 - 10000 of >10,000
DLBCL Trial in Ottawa, Toronto (DPX-Survivac, Cyclophosphamide)
Terminated
- Diffuse Large B-Cell Lymphoma
- DPX-Survivac
- Cyclophosphamide
-
Ottawa, Ontario, Canada
- +1 more
Jun 16, 2021
Breast Tumor Trial in China (Epirubicin plus Cyclophosphamide, Taxanes, Taxanes plus Carboplatin)
Recruiting
- Breast Neoplasm
- Epirubicin plus Cyclophosphamide
- +2 more
-
Fuding, Fujian, China
- +26 more
Mar 28, 2022
Class II Malocclusion Trial in Cairo (Mandibular Protraction Appliance, PowerScope Appliance)
Completed
- Class II Malocclusion
- Mandibular Protraction Appliance
- PowerScope Appliance
-
Cairo, EgyptAbubakr Mohamed Fouad
Oct 12, 2022
Gynecological Malignant Tumor, Solid Tumor Trial in Shanghai (BL-B01D1)
Not yet recruiting
- Gynecological Malignant Tumor
- Solid Tumor
-
Shanghai, Shanghai, ChinaFudan University ShangHai Cancer Center
Apr 9, 2023
Lyme Disease, Borrelia Infections Trial in Zürich (venous blood puncture)
Not yet recruiting
- Lyme Disease
- Borrelia Infections
- venous blood puncture
-
Zürich, SwitzerlandChidren's Hospital Zurich
Sep 13, 2023
Cancer Trial in Taipei (Hitachi's Heavy Ion Beam Therapy System HyBEAT)
Completed
- Cancer
- Hitachi's Heavy Ion Beam Therapy System HyBEAT
-
Taipei, TaiwanCancer Center, Taipei Veterans General Hospital
Mar 9, 2023
RLS Trial (Massage)
Not yet recruiting
- RLS
- Massage
- (no location specified)
Feb 21, 2022
Head and Neck Squamous Cell Cancer Trial in United States (Cetuximab, BYL719, IMRT (Intensity-Modulated Radiation Therapy))
Completed
- Head and Neck Squamous Cell Cancer
- Cetuximab
- +2 more
-
Basking Ridge, New Jersey
- +5 more
Oct 22, 2021
Nectin4-positive Advanced Malignant Solid Tumor Trial in Lishui, Wenzhou (CAR-T therapy for nectin4-positive malignant solid
Unknown status
- Nectin4-positive Advanced Malignant Solid Tumor
- CAR-T therapy for nectin4-positive malignant solid tumor
-
Lishui, Zhejiang, China
- +1 more
Nov 16, 2020
Nursing Home, Dementia, Staff Trial in Morbio Inferiore (Training on non-pharmacological therapies' methodology)
Completed
- Nursing Home
- +2 more
- Training on non-pharmacological therapies' methodology
-
Morbio Inferiore, SwitzerlandFondazione Casa San Rocco
Apr 13, 2023
![](/image/sponsor/university_of_campania_"luigi_vanvitelli")
Inflammatory Index asPredictor for Endometrial
Recruiting
- Endometrial Neoplasms
- Inflammatory Response
- Venous blood sample
- Surgical staging of endometrial cancer
-
Naples, ItalyUniversità degli Studi della Campania Luigi Vanvitelli
Dec 10, 2022
Ovarian Cancer, Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Toronto (Niraparib)
Not yet recruiting
- Ovarian Cancer
- +3 more
-
Toronto, Ontario, CanadaSunnybrook Research Institute
Jul 18, 2023
EGFR/ B7H3-positive Advanced Lung Cancer, EGFR/ B7H3-positive Advanced Triple-negative Breast Cancer Trial in Guangzhou
Recruiting
- EGFR/ B7H3-positive Advanced Lung Cancer
- EGFR/ B7H3-positive Advanced Triple-negative Breast Cancer
- EGFR/B7H3 CAR-T
-
Guangzhou, Guangdong, ChinaSecond Affiliated Hospital of Guangzhou Medical University
Apr 18, 2022
Non Small Cell Lung Cancer Trial in Durham (Ipilimumab, Paclitaxel, Cisplatin, Carboplatin)
Completed
- Non Small Cell Lung Cancer
- Ipilimumab
- Paclitaxel, Cisplatin, Carboplatin
-
Durham, North CarolinaDuke University Medical Center
Feb 24, 2021
Trelagliptin Tablets "Survey on Long-term Use in Type 2 Diabetes
Active, not recruiting
- Type 2 Diabetes Mellitus
-
Tokyo, JapanTakeda Selected Site
Oct 28, 2022
Hypertension Trial in New York (Community-to-Clinic Linkage Implementation Program in Barbershops (CLIP), Barbershop-Based
Recruiting
- Hypertension
- Community-to-Clinic Linkage Implementation Program in Barbershops (CLIP)
- Barbershop-Based Facilitation (BF)
-
New York, New YorkNYU Langone Health
Oct 28, 2022
NASH, NAFLD Trial in Hangzhou (GH509, Placebo)
Recruiting
- NASH
- NAFLD
- GH509
- Placebo
-
Hangzhou, Zhejiang, ChinaThe Affiliated Hospital of Hangzhou Normal University
Mar 26, 2023
COPD, Acute Exacerbation of COPD Trial in Taoyuan (cuirass ventilator (cuirass diameter 21 cm or 34 cm, Dima Italia
Recruiting
- Chronic Obstructive Pulmonary Disease
- Acute Exacerbation of COPD
- cuirass ventilator (cuirass diameter 21 cm or 34 cm, Dima Italia Srl.,Bologna, Italy)
- breathing training, and an educational program (relaxation techniques and a home pacing walking exercise)
-
Taoyuan, TaiwanChang Gung Memorial Hospital
Apr 12, 2021
Langerhans Cell Histiocytosis (LCH), Juvenile Xanthogranuloma (JXG), Rosai-Dorfman Disease (RDD) Trial (Mirdametinib)
Not yet recruiting
- Langerhans Cell Histiocytosis (LCH)
- +3 more
- (no location specified)
Nov 22, 2023
Healthy Trial in Philadelphia (Fish Oil, Safflower Oil, Ethanol)
Active, not recruiting
- Healthy
- Fish Oil
- +4 more
-
Philadelphia, PennsylvaniaInstitute for Translational Medicine and Therapeutics (ITMAT), U
Dec 22, 2022
Gastric Cancer Trial (OGT group, Overlap group)
Recruiting
- Gastric Cancer
- OGT group
- Overlap group
-
Guangzhou, Guangdong, ChinaXinhua Chen
Nov 2, 2022
Anogenital Wart Trial in Makassar (Topical Ethanol Extract (Piper crocatum), Trichloroacetic Acid Topical)
Not yet recruiting
- Anogenital Wart
- Topical Ethanol Extract (Piper crocatum)
- Trichloroacetic Acid Topical
-
Makassar, South Sulawesi, IndonesiaWahidin Sudirohusodo General Hospital
Nov 14, 2022
Hemay005, Atopic Dermatitis Trial in Shijiazhuang (Hemay005)
Recruiting
- Hemay005, Atopic Dermatitis
-
Shijiazhuang, Hebei, ChinaFirst Hospital of Hebei Medical University
Mar 14, 2023
Detect and Infer Severity of COPD by Intelligent Terminal Device
Enrolling by invitation
- COPD
-
Beijing, Beijing, China
- +9 more
Sep 19, 2022